Anna Vilgelm
Postdoctoral Fellow
Last active: 7/31/2013

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A (2013) EMBO Mol Med 5(1): 149-66
    › Primary publication · 23180582 (PubMed) · PMC3569660 (PubMed Central)
  2. RAF265 inhibits the growth of advanced human melanoma tumors. Su Y, Vilgelm AE, Kelley MC, Hawkins OE, Liu Y, Boyd KL, Kantrow S, Splittgerber RC, Short SP, Sobolik T, Zaja-Milatovic S, Dahlman KB, Amiri KI, Jiang A, Lu P, Shyr Y, Stuart DD, Levy S, Sosman JA, Richmond A (2012) Clin Cancer Res 18(8): 2184-98
    › Primary publication · 22351689 (PubMed) · PMC3724517 (PubMed Central)
  3. [The coordinated interaction of multifunctional members of p53 family determines many key processes in multicellular organisms]. Vilgelm AE, Zaika AI, Prasolov VS (2011) Mol Biol (Mosk) 45(1): 180-97
    › Primary publication · 21485507 (PubMed)
  4. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors. Vilgelm AE, Hong SM, Washington MK, Wei J, Chen H, El-Rifai W, Zaika A (2010) Oncogene 29(43): 5861-8
    › Primary publication · 20676143 (PubMed) · PMC4152004 (PubMed Central)
  5. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Wei J, Nagy TA, Vilgelm A, Zaika E, Ogden SR, Romero-Gallo J, Piazuelo MB, Correa P, Washington MK, El-Rifai W, Peek RM, Zaika A (2010) Gastroenterology 139(4): 1333-43
    › Primary publication · 20547161 (PubMed) · PMC2949494 (PubMed Central)
  6. Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors. Vilgelm AE, Washington MK, Wei J, Chen H, Prassolov VS, Zaika AI (2010) Mol Cancer Ther 9(3): 693-705
    › Primary publication · 20197393 (PubMed) · PMC2838189 (PubMed Central)
  7. Therapeutic prospects for p73 and p63: rising from the shadow of p53. Vilgelm A, El-Rifai W, Zaika A (2008) Drug Resist Updat 11(4-5): 152-63
    › Primary publication · 18801697 (PubMed) · PMC2585826 (PubMed Central)
  8. Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Wei J, O'Brien D, Vilgelm A, Piazuelo MB, Correa P, Washington MK, El-Rifai W, Peek RM, Zaika A (2008) Gastroenterology 134(5): 1412-23
    › Primary publication · 18343378 (PubMed) · PMC2430883 (PubMed Central)
  9. DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function. Vilgelm A, Wei JX, Piazuelo MB, Washington MK, Prassolov V, El-Rifai W, Zaika A (2008) Oncogene 27(15): 2170-6
    › Primary publication · 17952118 (PubMed) · PMC4066670 (PubMed Central)
  10. [RNA interference: biology and perspectives of application in biomedicine and biotechnology]. Vil'gel'm AE, Chumakov SP, Prasolov VS (2006) Mol Biol (Mosk) 40(3): 387-403
    › Primary publication · 16813159 (PubMed)
  11. The gastrin gene promoter is regulated by p73 isoforms in tumor cells. Tomkova K, El-Rifai W, Vilgelm A, Kelly MC, Wang TC, Zaika AI (2006) Oncogene 25(44): 6032-6
    › Primary publication · 16636659 (PubMed)
  12. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A (2006) Cancer Res 66(7): 3375-80
    › Primary publication · 16585156 (PubMed)